Skip to main content
Erschienen in: Journal of Cancer Survivorship 3/2010

01.09.2010 | Policy Papers

The Italian response to cancer survivorship research and practice: developing an evidence base for reform

verfasst von: Vittorio Mattioli, Rosanna Montanaro, Francesca Romito

Erschienen in: Journal of Cancer Survivorship | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Improvement in cancer survival rates have increased longevity but have also revealed physical and psycho-social sequelae of long-term survivorship and raised many questions regarding how to assess, treat, and prevent these survival-related problems. The United States, Australia, and some northern European Union countries have already started to address these issues. Italy still needs to take up this challenge, taking into account its specific social and cultural background that shapes a different survivorship scenario.

Methods

This brief report summarizes the concept of cancer survivorship and the response to this emerging public health issue in Italy. Two current nationwide research programs on long-term cancer survivorship and post-cancer pain are described to provide readers with a perspective of how Italy is seeking to increase the understanding of the needs and problems of cancer survivors.

Implications for cancer survivors

The results of these nationwide research programs will provide an evidence base for reforming the national care plans to address the needs of the growing number of Italian people with a history of cancer. It is hoped that this description of Italy’s response to this public health challenge will offer some insight into how Italy is responding to the health and psychosocial needs of cancer survivors.
Literatur
1.
Zurück zum Zitat Feuerstein M, editor. Handbook of cancer survivorship. New York: Springer; 2007. Feuerstein M, editor. Handbook of cancer survivorship. New York: Springer; 2007.
2.
Zurück zum Zitat Wingo PA, Howe HL, Thun MJ, Ballard-Barbash R, Ward E, Brown ML, et al. A national framework for cancer surveillance in the United States. Cancer Causes Control. 2005;16(2):151–70.CrossRefPubMed Wingo PA, Howe HL, Thun MJ, Ballard-Barbash R, Ward E, Brown ML, et al. A national framework for cancer surveillance in the United States. Cancer Causes Control. 2005;16(2):151–70.CrossRefPubMed
3.
Zurück zum Zitat Rowland JH. Cancer survivorship: rethinking the cancer control continuum. Semin Oncol Nurs. 2008;24(3):145–52.CrossRefPubMed Rowland JH. Cancer survivorship: rethinking the cancer control continuum. Semin Oncol Nurs. 2008;24(3):145–52.CrossRefPubMed
4.
Zurück zum Zitat De Angelis R, Grande E, Inghelmann R, Francisci S, Micheli A, Baili P, et al. Cancer prevalence estimates in Italy from 1970 to 2010. Tumori. 2007;93(4):392–7.PubMed De Angelis R, Grande E, Inghelmann R, Francisci S, Micheli A, Baili P, et al. Cancer prevalence estimates in Italy from 1970 to 2010. Tumori. 2007;93(4):392–7.PubMed
5.
Zurück zum Zitat Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer. 2009;45(6):931–91.CrossRefPubMed Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer. 2009;45(6):931–91.CrossRefPubMed
6.
Zurück zum Zitat Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, et al. EUROCARE-3: survival of cancer patients diagnosed 1990–94--results and commentary. Ann Oncol. 2003;14 Suppl 5:v61–v118.CrossRefPubMed Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, et al. EUROCARE-3: survival of cancer patients diagnosed 1990–94--results and commentary. Ann Oncol. 2003;14 Suppl 5:v61–v118.CrossRefPubMed
7.
Zurück zum Zitat Inghelmann R, Grande E, Francisci S, De Angelis R, Micheli A, Verdecchia A, et al. National estimates of cancer patients survival in Italy: a model-based method. Tumori. 2005;91(2):109–15.PubMed Inghelmann R, Grande E, Francisci S, De Angelis R, Micheli A, Verdecchia A, et al. National estimates of cancer patients survival in Italy: a model-based method. Tumori. 2005;91(2):109–15.PubMed
8.
Zurück zum Zitat Francisci S, Capocaccia R, Grande E, Santaquilani M, Simonetti A, Allemani C, et al. The cure of cancer: a European perspective. Eur J Cancer. 2009;45(6):1067–79.CrossRefPubMed Francisci S, Capocaccia R, Grande E, Santaquilani M, Simonetti A, Allemani C, et al. The cure of cancer: a European perspective. Eur J Cancer. 2009;45(6):1067–79.CrossRefPubMed
9.
Zurück zum Zitat Albini A, Pennesi G, Donatelli F, Cammarota R, De Flora S, Noonan DM. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst. 2010;6 102(1):14–25. Albini A, Pennesi G, Donatelli F, Cammarota R, De Flora S, Noonan DM. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst. 2010;6 102(1):14–25.
10.
Zurück zum Zitat Bria E, Cuppone F, Fornier M, Nisticò C, Carlini P, Milella M, et al. Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials. Breast Cancer Res Treat. 2008;109(2):231–9.CrossRefPubMed Bria E, Cuppone F, Fornier M, Nisticò C, Carlini P, Milella M, et al. Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials. Breast Cancer Res Treat. 2008;109(2):231–9.CrossRefPubMed
11.
Zurück zum Zitat Hewitt M, Greenfiels S, Stovall E, editors. From cancer patient to cancer survivor. Lost in transition. Committee on cancer survivorship: Improving care and quality of life. Washington: The National Academy; 2006. Hewitt M, Greenfiels S, Stovall E, editors. From cancer patient to cancer survivor. Lost in transition. Committee on cancer survivorship: Improving care and quality of life. Washington: The National Academy; 2006.
12.
Zurück zum Zitat Aziz NM, Rowland JH. Trends and advances in cancer survivorship research: challenge and opportunity. Semin Radiat Oncol. 2003;13(3):248–66.CrossRefPubMed Aziz NM, Rowland JH. Trends and advances in cancer survivorship research: challenge and opportunity. Semin Radiat Oncol. 2003;13(3):248–66.CrossRefPubMed
13.
Zurück zum Zitat Miller KD, Triano LR. Medical issues in cancer survivors-a review. Cancer J. 2008;14(6):375–87.CrossRefPubMed Miller KD, Triano LR. Medical issues in cancer survivors-a review. Cancer J. 2008;14(6):375–87.CrossRefPubMed
14.
Zurück zum Zitat Mao JJ, Armstrong K, Bowman MA, Xie SX, Kadakia R, Farrar JT. Symptom burden among cancer survivors: impact of age and comorbidity. J Am Board Fam Med. 2007;20:434–43.CrossRefPubMed Mao JJ, Armstrong K, Bowman MA, Xie SX, Kadakia R, Farrar JT. Symptom burden among cancer survivors: impact of age and comorbidity. J Am Board Fam Med. 2007;20:434–43.CrossRefPubMed
15.
Zurück zum Zitat Wolff SN. The burden of cancer survivorship. In: Feuerstein M, editor. Handbook of cancer survivorship. New York: Springer; 2007. Wolff SN. The burden of cancer survivorship. In: Feuerstein M, editor. Handbook of cancer survivorship. New York: Springer; 2007.
16.
Zurück zum Zitat Ganz P. Survivorship: adult cancer survivors. Prim Care. 2009;36(4):721–41.PubMed Ganz P. Survivorship: adult cancer survivors. Prim Care. 2009;36(4):721–41.PubMed
17.
Zurück zum Zitat Earle CC. Quality of care. In: Feuerstein M, editor. Handbook of cancer survivorship. New York: Springer; 2007. Earle CC. Quality of care. In: Feuerstein M, editor. Handbook of cancer survivorship. New York: Springer; 2007.
18.
Zurück zum Zitat Stein K, Smith T, Kim Y, Mehta CC, Stafford J, Spillers RL, et al. The American Cancer Society’s Studies of Cancer Survivors: the largest, most diverse investigation of long-term cancer survivors so far. Am J Nurs. 2006;106(3 Suppl):83–5.PubMed Stein K, Smith T, Kim Y, Mehta CC, Stafford J, Spillers RL, et al. The American Cancer Society’s Studies of Cancer Survivors: the largest, most diverse investigation of long-term cancer survivors so far. Am J Nurs. 2006;106(3 Suppl):83–5.PubMed
19.
Zurück zum Zitat Haylock PJ. The shifting paradigm of cancer care. The many needs of cancer survivors are starting to attract attention. Am J Nurs. 2006;106(3 suppl):16–9.PubMed Haylock PJ. The shifting paradigm of cancer care. The many needs of cancer survivors are starting to attract attention. Am J Nurs. 2006;106(3 suppl):16–9.PubMed
20.
Zurück zum Zitat Mattioli V. Cancer survivorship: An emerging problem in Italy. From the American data to Italian Project PIO7. Review. Spoleto: Human Health Foundation Onlus, 2008. Mattioli V. Cancer survivorship: An emerging problem in Italy. From the American data to Italian Project PIO7. Review. Spoleto: Human Health Foundation Onlus, 2008.
21.
Zurück zum Zitat Levy MH, Chwistek M, Mehta RS. Management of chronic pain in cancer survivors. Cancer J. 2008;14(6):401–9.CrossRefPubMed Levy MH, Chwistek M, Mehta RS. Management of chronic pain in cancer survivors. Cancer J. 2008;14(6):401–9.CrossRefPubMed
22.
Zurück zum Zitat Alfano CM, Rowland JH. Recovery issues in cancer survivorship: a new challenge for supportive care. Cancer J. 2006;12(5):432–43.CrossRefPubMed Alfano CM, Rowland JH. Recovery issues in cancer survivorship: a new challenge for supportive care. Cancer J. 2006;12(5):432–43.CrossRefPubMed
23.
Zurück zum Zitat Palomano RC, Farrar JT. Pain and neuropathy in cancer survivors. Surgery, radiation, and chemotherapy can cause pain; research could improve its detection and treatment. Am J Nurs. 2006;106(3 Suppl):39–47. Palomano RC, Farrar JT. Pain and neuropathy in cancer survivors. Surgery, radiation, and chemotherapy can cause pain; research could improve its detection and treatment. Am J Nurs. 2006;106(3 Suppl):39–47.
24.
Zurück zum Zitat Burton AW, Fanciullo GJ, Beasley RD, Fisch MJ. Chronic pain in cancer survivors: a new frontier. Pain Med. 2007;8(2):189–98.CrossRefPubMed Burton AW, Fanciullo GJ, Beasley RD, Fisch MJ. Chronic pain in cancer survivors: a new frontier. Pain Med. 2007;8(2):189–98.CrossRefPubMed
25.
Zurück zum Zitat Sun V, Borneman T, Piper B, Koczywas M, Ferrell B. Barriers to pain assessment and management in cancer Survivorship. J Cancer Surviv. 2008;2(1):65–71.CrossRefPubMed Sun V, Borneman T, Piper B, Koczywas M, Ferrell B. Barriers to pain assessment and management in cancer Survivorship. J Cancer Surviv. 2008;2(1):65–71.CrossRefPubMed
26.
Zurück zum Zitat Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M, et al. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer. 2000;89(7):1634–46CrossRefPubMed Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M, et al. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer. 2000;89(7):1634–46CrossRefPubMed
27.
Zurück zum Zitat Reyes-Gibby CC, Aday LA, Anderson KO, Mendoza TR, Cleeland CS. Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. J Pain Symptom Manage. 2006;32(2):118–28.CrossRefPubMed Reyes-Gibby CC, Aday LA, Anderson KO, Mendoza TR, Cleeland CS. Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. J Pain Symptom Manage. 2006;32(2):118–28.CrossRefPubMed
28.
Zurück zum Zitat Romito F, Montanaro R, Corvasce C, Di Bisceglie M, Mattioli V. Is cancer-related fatigue more strongly correlated to haematological or to psychological factors in cancer patients? Support Care Cancer. 2008;16(8):943–6.CrossRefPubMed Romito F, Montanaro R, Corvasce C, Di Bisceglie M, Mattioli V. Is cancer-related fatigue more strongly correlated to haematological or to psychological factors in cancer patients? Support Care Cancer. 2008;16(8):943–6.CrossRefPubMed
29.
Zurück zum Zitat Wang XS. Pathophysiology of cancer-related fatigue. Clin J Oncol Nurs. 2008;12(5 Suppl):11–20.CrossRefPubMed Wang XS. Pathophysiology of cancer-related fatigue. Clin J Oncol Nurs. 2008;12(5 Suppl):11–20.CrossRefPubMed
30.
Zurück zum Zitat Apkarian AV, Baliki MN, Geha PY. Towards a theory of chronic pain. Prog Neurobiol. 2009;87(2):81–97.CrossRefPubMed Apkarian AV, Baliki MN, Geha PY. Towards a theory of chronic pain. Prog Neurobiol. 2009;87(2):81–97.CrossRefPubMed
Metadaten
Titel
The Italian response to cancer survivorship research and practice: developing an evidence base for reform
verfasst von
Vittorio Mattioli
Rosanna Montanaro
Francesca Romito
Publikationsdatum
01.09.2010
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 3/2010
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-010-0143-9

Weitere Artikel der Ausgabe 3/2010

Journal of Cancer Survivorship 3/2010 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.